Accelerating Discovery of Functional Mutant Alleles in Cancer.

نویسندگان

  • Matthew T Chang
  • Tripti Shrestha Bhattarai
  • Alison M Schram
  • Craig M Bielski
  • Mark T A Donoghue
  • Philip Jonsson
  • Debyani Chakravarty
  • Sarah Phillips
  • Cyriac Kandoth
  • Alexander Penson
  • Alexander Gorelick
  • Tambudzai Shamu
  • Swati Patel
  • Christopher Harris
  • JianJiong Gao
  • Selcuk Onur Sumer
  • Ritika Kundra
  • Pedram Razavi
  • Bob T Li
  • Dalicia N Reales
  • Nicholas D Socci
  • Gowtham Jayakumaran
  • Ahmet Zehir
  • Ryma Benayed
  • Maria E Arcila
  • Sarat Chandarlapaty
  • Marc Ladanyi
  • Nikolaus Schultz
  • José Baselga
  • Michael F Berger
  • Neal Rosen
  • David B Solit
  • David M Hyman
  • Barry S Taylor
چکیده

Most mutations in cancer are rare, which complicates the identification of therapeutically significant mutations and thus limits the clinical impact of genomic profiling in patients with cancer. Here, we analyzed 24,592 cancers including 10,336 prospectively sequenced patients with advanced disease to identify mutant residues arising more frequently than expected in the absence of selection. We identified 1,165 statistically significant hotspot mutations of which 80% arose in 1 in 1,000 or fewer patients. Of 55 recurrent in-frame indels, we validated that novel AKT1 duplications induced pathway hyperactivation and conferred AKT inhibitor sensitivity. Cancer genes exhibit different rates of hotspot discovery with increasing sample size, with few approaching saturation. Consequently, 26% of all hotspots in therapeutically actionable oncogenes were novel. Upon matching a subset of affected patients directly to molecularly targeted therapy, we observed radiographic and clinical responses. Population-scale mutant allele discovery illustrates how the identification of driver mutations in cancer is far from complete.Significance: Our systematic computational, experimental, and clinical analysis of hotspot mutations in approximately 25,000 human cancers demonstrates that the long right tail of biologically and therapeutically significant mutant alleles is still incompletely characterized. Sharing prospective genomic data will accelerate hotspot identification, thereby expanding the reach of precision oncology in patients with cancer. Cancer Discov; 8(2); 174-83. ©2017 AACR.This article is highlighted in the In This Issue feature, p. 127.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Evaluation of BRAF-V600E gene mutation in colon tissue of patients with colorectal cancer in Iran

Background: Colorectal cancer is one of the most common types of cancer and the cause of death of a large number of patients and requires investigating the causes of the disease and adopting targeted therapies. Considering the diagnostic, therapeutic, and prognostic significance of genetic markers, in the present study BRAF-V600E gene mutation was evaluated in tissue samples of colorectal cance...

متن کامل

Systematic Functional Interrogation of Rare Cancer Variants Identifies Oncogenic Alleles.

UNLABELLED Cancer genome characterization efforts now provide an initial view of the somatic alterations in primary tumors. However, most point mutations occur at low frequency, and the function of these alleles remains undefined. We have developed a scalable systematic approach to interrogate the function of cancer-associated gene variants. We subjected 474 mutant alleles curated from 5,338 tu...

متن کامل

High Frequency of IVS10nt546 Linked to VNTR8 in Iranian PKU Patients from Fars Province

Dear Editor Analysis of the phenylalanine hydroxylase (PAH McKusick 261600) gene in different populations has revealed more than 320 different mutations associated with phenylketonuria (PKU). One of these mutations, IVS10nt546, results in severe PAH deficiency due to defective mRNA splicing. It accounts for about 40 percent of all mutant alleles in Turkish and between 10 to 20 percent of all mu...

متن کامل

بررسی فراوانی پلی مورفیسم جایگاه SspI در اینترون II ژن بتا گلوبین در استان مازندران

Background and purpose: Due to the high annual birth rate of thalassemia major in our country, its prevention by prenatal diagnosis is of important priority. Gene mutation remains unknown in 10-20% of thalassemia trait people in Iran. In these cases, linkage analysis using polymorphic sites which are located near or within the gene is necessary to follow the mutant or the normal chromosome. Ssp...

متن کامل

افزایش خطر ابتلا به سرطان سینه با کاهش تعداد تکرارهای VNTR پروموتر ژن RHOB

Background & Aims: Breast cancer is the most common cancer among women and the second most common cause of death from cancer. In Iran, of 10 to 15 women, one woman has the risk of breast cancers. The RHOB gene is one of the genes that is associated with cancer and the coding of the protein with GTPase functional and studies have shown that expression of this gene increases in breast cancer...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Cancer discovery

دوره 8 2  شماره 

صفحات  -

تاریخ انتشار 2018